Health habits of patients with schizophrenia: A general pattern?;Das gesundheitsverhalten schizophrener erkrankter patienten: Ein typisches verhaltensmuster?

Neuropsychiatrie

Volumn 22, Issue 2, 2008, Pages 100-111

  Roick, Christiane ^a   Schindler, Jana ^b   Angermeyer, Matthias C ^c   Fritz Wieacker, Anita ^a   Riedel Heller, Steffi ^a   Frühwald, Stefan ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Klinik für Psychiatrie und Psychiatrie

^c Center for Public Mental Health

^d Klinik und Poliklinik für Psychiatrie ^*

Author keywords

Austria; Germany; Health habits; Schizophrenia

Indexed keywords

ADULT; ARTICLE; AUSTRIA; CIGARETTE SMOKING; DRINKING; EATING; FEMALE; GERMANY; HABIT; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PHYSICAL ACTIVITY; REGRESSION ANALYSIS; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; UNEMPLOYMENT;

ADULT; ALCOHOL DRINKING; AUSTRIA; EXERCISE; FEMALE; FOOD HABITS; GERMANY; HEALTH BEHAVIOR; HEALTH SURVEYS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PILOT PROJECTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SOCIOECONOMIC FACTORS;

EID: 49449096935     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Agerbo E., Byrne M., Eaton W.W., Mortensen P.B.: Marital and labor market status in the long run in schizophrenia. Archives of General Psychiatry 61, 28-33 (2004).
2. Allison D.B., Casey D.E.: Antipsychotic-induced weight gain: a review of the literature. Journal of Clinical Psychiatry 62 Suppl 7, 22-31 (2001).
3. Brown S.: Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry 171, 502-8 (1997).
4. Brown S., Birtwistle J., Roe L., Thompson C.: The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29, 697-701 (1999).
5. Brown S., Inskip H., Barraclough B.: Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 177, 212-7 (2000).
6. Center for disease control and prevention: Prevalence of healthy lifestyle characteristics - Michigan, 1998 and 2000. Morbidity and Mortality Weekly Report 50, 758-61 (2001).
7. Connolly M., Kelly C.: Lifestyle and physical health in schizophrenia. Advances in Psychiatric Treatment 11, 125-32 (2005).
8. Daumit G.L., Goldberg R.W., Anthony C, Dickerson F., Brown C.H., Kreyenbuhl J., et al.: Physical activity patterns in adults with severe mental illness. Journal of Nervous and Mental Disorders 193, 641-6 (2005).
9. de Leon J., Tracy J., McCann E., McGrory A., Diaz F.J.: Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophrenia Research 56, 55-65 (2002).
10. Dickerson F.B., Pater A., Origoni A.E.: Health behaviors and health status of older women with schizophrenia. Psychiatric Services 53, 882-4 (2002).
11. Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., et al.: Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin 26, 903-12 (2000).
12. Elizondo-Armendariz J.J., Guillen Grima F., Aguinaga Ontoso I.: Prevalence of physical activity and its relationship to sociodemographic variables and life-styles in the age 18-65 population of Pamplona, Spain. Revista Española de Salud Pública 79, 559-67 (2005).
13. Gillis A.J.: Determinants of a health-promoting lifestyle: an integrative review. Journal of Advanced Nursing 18, 345-53 (1993).
14. Hughes J.R., McHugh P., Holtzman S.: Caffeine and schizophrenia. Psychiatric Services 49, 1415-7 (1998).
15. Jeste D.V., Gladsjo J.A., Lindamer L.A., Lacro J.P.: Medical comorbidity in schizophrenia. Schizophrenia Bulletin 22, 413-30 (1996).
16. Johansson L., Thelle D.S., Solvoll K., Bjorneboe G.E., Drevon C.A.: Healthy dietary habits in relation to social determinants and lifestyle factors. British Journal of Nutrition 81, 211-20 (1999).
17. Koga M., Nakayama K.: Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved. Acta Psychiatrica Scandinavica 112, 75-6 (2005).
18. Kumari V., Postma P.: Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioral Reviews 29, 1021-34 (2005).
19. Land Niederösterreich: Das Land Niederösterreich. 2006: http://www01.noel. gv.at/scripts/ru/ru2/stat.asp?NR=30201.
20. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lonnqvist J.: Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry 58, 573-8 (2001).
21. Lucas P.B., Pickar D., Kelsoe J., Rapaport M., Pato C., Hommer D.: Effects of the acute administration of caffeine in patients with schizophrenia. Biological Psychiatry 28, 35-40 (1990).
22. Manzoli L., Di Giovanni P., Dragani V., Ferrandino M.G., Morano J.P., Rauti I., et al.: Smoking behaviour, cessation attempts and the influence of parental smoking in older adult women: a cross-sectional analysis from Italy. Public Health 119, 670-8 (2005).
23. McChargue D.E., Gulliver S.B., Hitsman B.: Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 97, 785-93 (2002).
24. McCreadie R.G.: Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. British Journal of Psychiatry 183, 534-9 (2003).
25. McCreadie R.G., Kelly C., Connolly M., Williams S., Baxter G., Lean M., et al.: Dietary improvement in people with schizophrenia: randomised controlled trial. British Journal of Psychiatry 187. 346-51 (2005).
26. McCreadie R.G., Macdonald E., Blacklock C., Tilak-Singh D., Wiles D., Halliday J., et al.: Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. British Medical Journal 317, 784-5 (1998).
27. McEvoy J.P.: Schizophrenia, substance misuse, and smoking. Current Opinion in Psychiatry 13, 15-9 (2000).
28. McEvoy J.P., Allen T.B.: Substance abuse (including nicotine) in schizophrenic patients. Current Opinion in Psychiatry 16, 199-205 (2003).
29. Möller H.-J., Laux G., Deister A.: Psychiatrie und Psychotherapie. Thieme, Stuttgart 2001.
30. Munk-Jorgensen P., Mors O., Mortensen P.B., Ewald H.: The schizophrenic patient in the somatic hospital. Acta Psychiatrica Scandinavica 407, S96-9 (2000).
31. Osby U., Correia N., Brandt L., Ekbom A., Sparen P.: Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research 45, 21-8 (2000).
32. Painter J., Rah J.H., Lee Y.K.: Comparison of international food guide pictorial representations. Journal of the American Dietetic Association 102, 483-9 (2002).
33. Paton C., Esop R., Young C., Taylor D.: Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatrica Scandinavica 110, 299-305 (2004).
34. Peet M.: Diet, diabetes and schizophrenia: review and hypothesis. British Journal of Psychiatry 47, S102-5 (2004).
35. Pronk N.P., Anderson L.H., Crain A.L., Martinson B.C., O'Connor P.J., Sherwood N.E., et al.: Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. American Journal of Preventive Medicine 27, 25-33 (2004).
36. Roick C., Fritz-Wieacker A., Matschinger H., Heider D., Schindler J., Riedel-Heller S., et al.: Health habits of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology 42, 268-76 (2007).
37. Ryan M.C., Collins P., Thakore J.H.: Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. American Journal of Psychiatry 160, 284-9 (2003).
38. Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., Rosenheck R.: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159, 561-6 (2002).
39. Silverstone T., Smith G., Goodall E.: Prevalence of obesity in patients receiving depot antipsychotics. British Journal of Psychiatry 153, 214-7 (1988).
40. Strassnig M., Brar J.S., Ganguli R.: Nutritional assessment of patients with schizophrenia: a preliminary study. Schizophrenia Bulletin 29, 393-7 (2003).
41. Tardieu S., Micallef J., Gentile S., Blin O.: Weight gain profiles of new antipsychotics: public health consequences. Obesity Reviews 4, 129-38 (2003).
42. Thefeld W., Stolzenberg H., Bellach B.M.: Bundes-Gesundheitssurvey: Response, Zusammensetzung der Teilnehmer und Non-Responder-Analyse. Gesundheitswesen 61, S57-61 (1999).
43. Vieweg W.V., Sood A.B., Pandurangi A., Silverman J.J.: Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain? Acta Psychiatrica Scandinavica 111, 177-84 (2005).
44. von Bothmer M.I., Fridlund B.: Gender differences in health habits and in motivation for a healthy lifestyle among Swedish university students. Nursing & Health Sciences 7, 107-18 (2005).
45. Week S., Mennel F.: Stadt Plauen. 2006: http://www.plauen.de/.
46. World Health Organization: The ICD-10 Classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organisation, Geneva 1992.
47. World Health Organization: Adult per capita alcohol consumption. 2001: http://globalatlas.who.int/globalatlas/ dataQuery/reportData.asp?rptType=1.
48. World Health Organization: BMI / Overweight / Obesity - prevalence. 2002: http://www.who.int/ncd_surveillance/infobase/web/InfoBasePolicyMaker/ CountryProfiles/QuickCompare. aspx?DM=5&Countries=40%2c276&Y ear=2002&sf1=all&Sex=all.
49. World Health Organization: Mortality - Communicable, maternal, perinatal and nutritional conditions. 2002: http:// www.who.int/ncd_surveillance/infobase/ web/InfoBasePolicyMaker/CountryProfiles/QuickCompare.aspx?DM=1 0&Countries=40,276&Year=2002&sf1 =all&Sex=all.
50. World Health Organization: The World Health Report 2002. 2002: http://www. who.int/whr/2002/en/.